Expression of Estrogen Receptor α by Decidual Macrophages in Preeclampsia.
decidua
estrogen receptors
inflammation
macrophages
polarization
preeclampsia
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
14 Feb 2021
14 Feb 2021
Historique:
received:
10
12
2020
revised:
10
02
2021
accepted:
11
02
2021
entrez:
6
3
2021
pubmed:
7
3
2021
medline:
7
3
2021
Statut:
epublish
Résumé
Preeclampsia is a gestation-associated hypertensive syndrome that threatens the life and health of the mother and the child. The condition is presumably caused by systemic failure with a strong involvement of innate immunity. In particular, it has been associated with flexible phenotypes of macrophages, which depend on the molecules circulating in the blood and tissue fluid, such as cytokines and hormones. This study aimed at a comparative evaluation of pro-inflammatory (TNFα) and anti-inflammatory (CD206, MMP9, HGF) markers, as well as the levels of estrogen receptor α, expressed by decidual macrophages in normal pregnancy and in patients with early- and late-onset preeclampsia. The tissue samples of decidua basalis were examined by immunohistochemistry and Western blotting. Isolation of decidual macrophages and their characterization were performed using cultural methods, flow cytometry and real-time PCR. Over 50% of the isolated decidual macrophages were positive for the pan-macrophage marker CD68. In the early-onset preeclampsia group, the levels of estrogen receptor α in decidua were significantly decreased. Furthermore, significantly decreased levels of HGF and CD206 were observed in both preeclampsia groups compared with the control group. The observed downregulation of estrogen receptor α, HGF and CD206 may contribute to the balance of pro- and anti-inflammatory macrophages and thereby to pathogenesis of preeclampsia.
Identifiants
pubmed: 33672970
pii: biomedicines9020191
doi: 10.3390/biomedicines9020191
pmc: PMC7917975
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Russian Science Foundation
ID : 17-15-01419
Organisme : President Grant for Government Support of Young Russian Scientists
ID : 075-15-2019-1120
Références
Oncotarget. 2016 Aug 9;7(32):52294-52306
pubmed: 27418133
Syst Biol Reprod Med. 2018 Oct;64(5):324-339
pubmed: 29965778
J Invest Dermatol. 2014 Sep;134(9):2447-2457
pubmed: 24769859
Mol Med Rep. 2013 Mar;7(3):981-5
pubmed: 23291833
J Clin Endocrinol Metab. 2015 Jan;100(1):E50-8
pubmed: 25303489
Hypertens Res. 2007 Mar;30(3):205-11
pubmed: 17510501
Int J Biochem Cell Biol. 2014 Sep;54:272-85
pubmed: 24886696
Anticancer Res. 2016 Jun;36(6):2839-47
pubmed: 27272795
Nat Immunol. 2013 Oct;14(10):1054-63
pubmed: 23995234
Cell Immunol. 2015 Apr;294(2):63-9
pubmed: 25682174
Lancet. 2005 Feb 26-Mar 4;365(9461):785-99
pubmed: 15733721
Medicine (Baltimore). 2019 Apr;98(14):e15080
pubmed: 30946359
J Mol Endocrinol. 2002 Aug;29(1):125-35
pubmed: 12200234
Hum Reprod. 2005 Jul;20(7):2004-13
pubmed: 15831511
Immunol Invest. 2008;37(5):535-64
pubmed: 18716937
Am J Obstet Gynecol. 2010 Nov;203(5):477.e1-9
pubmed: 20691412
PLoS One. 2008 Apr 30;3(4):e2078
pubmed: 18446208
Physiol Rev. 2001 Oct;81(4):1535-65
pubmed: 11581496
Bioinformatics. 2003 Jul 22;19(11):1439-40
pubmed: 12874059
Immunobiology. 2017 Jan;222(1):75-81
pubmed: 26876591
PLoS One. 2018 Jan 11;13(1):e0191040
pubmed: 29324807
Hypertension. 2013 Feb;61(2):480-7
pubmed: 23319542
Immunol Lett. 2005 Feb 15;97(1):107-13
pubmed: 15626482
Front Immunol. 2017 Feb 10;8:108
pubmed: 28239379
Endocr Rev. 2017 Apr 1;38(2):123-144
pubmed: 28323944
Am J Pathol. 2011 Feb;178(2):709-17
pubmed: 21281803
Mol Med Rep. 2017 Nov;16(5):5997-6003
pubmed: 28849224
Vasc Health Risk Manag. 2015 Jul 15;11:403-15
pubmed: 26203257
Yale J Biol Med. 2012 Mar;85(1):105-18
pubmed: 22461749
Circ Res. 2002 Nov 1;91(9):814-20
pubmed: 12411396
Int J Mol Sci. 2020 Apr 08;21(7):
pubmed: 32276444
Front Immunol. 2019 Oct 18;10:2317
pubmed: 31681264
N Engl J Med. 2002 Jan 31;346(5):340-52
pubmed: 11821512
Int J Mol Sci. 2019 Jul 28;20(15):
pubmed: 31357698
J Cell Physiol. 2021 Mar;236(3):1875-1888
pubmed: 32716106
Am J Reprod Immunol. 2004 Feb;51(2):117-22
pubmed: 14748837
Vaccine. 2016 Dec 1;34(49):6047-6056
pubmed: 27743648
Arch Gynecol Obstet. 2011 Sep;284(3):551-7
pubmed: 20941502
Int J Nanomedicine. 2017 Oct 31;12:8009-8023
pubmed: 29184401
J Immunol. 2011 Oct 1;187(7):3671-82
pubmed: 21890660
Am J Reprod Immunol. 2008 Nov;60(5):383-404
pubmed: 19238747
Circ Res. 2019 Mar 29;124(7):1094-1112
pubmed: 30920918
Int J Mol Sci. 2018 May 17;19(5):
pubmed: 29772777
Pregnancy Hypertens. 2018 Jan;11:18-25
pubmed: 29523268
Am J Obstet Gynecol. 2011 Mar;204(3):193-201
pubmed: 21094932
Front Immunol. 2017 Feb 09;8:120
pubmed: 28232836
Cytokine. 2017 Oct;98:97-106
pubmed: 28094206
Clin Exp Immunol. 2003 Mar;131(3):498-505
pubmed: 12605704
Int J Mol Sci. 2020 Jun 18;21(12):
pubmed: 32570961
PLoS One. 2009;4(5):e5539
pubmed: 19440537
Curr Hypertens Rep. 2017 Aug;19(8):61
pubmed: 28689331
J Bone Miner Res. 2018 May;33(5):899-908
pubmed: 29281118
Reprod Biol Endocrinol. 2018 Dec 5;16(1):122
pubmed: 30518376
J Clin Endocrinol Metab. 1997 Aug;82(8):2726-30
pubmed: 9253361
Int J Biochem Cell Biol. 2018 Dec;105:35-40
pubmed: 30266525
Indian J Med Res. 2016 Dec;144(6):823-830
pubmed: 28474619